1 year ago
Non Hodgkin’s Lymphoma CAR-T Treatment In the past, cancer was primarily treated with surgery, chemotherapy, and radiation therapy. In recent years, cancer immunotherapy, which stimulates and...
1 year ago
Kymriah Treatment: A Comprehensive Overview Kymriah, also known as tisagenlecleucel, is a revolutionary treatment in the field of oncology, specifically designed for certain types of blood cancers....
1 year ago
Kymriah Therapy: A Revolutionary Approach in Cancer Treatment Kymriah therapy, also known as tisagenlecleucel, represents a groundbreaking advancement in the field of oncology. This innovative trea...
1 year ago
Kymriah Product Insert Basic Information on Kymriah English Name: Tisagenlecleucel Trade Name: Kymriah Target: CD19 Indications: Acute lymphoblastic leukemia, Diffuse large B-cell lymphoma Develope...
1 year ago
Blood Cancer Solution Including leukemia, lymphoma, multiple myeloma, and others. Blood Cancer #leukemia #lymphoma #multiplemyeloma #Hematologic malignancies are a group of malignant diseases ori...
1 year ago
**แสงแห่งความหวังใหม่: การเดินทางเพื่อการรักษาข้ามพรมแดนของผู้ป่วยชาวไทย** ที่แผนกโลหิตวิทยา โรงพยาบาลตงจี้เซี่ยงไฮ้ ผู้อำนวยการหลี่ผิง แพทย์ผู้รับผิดชอบการรักษาคุณ P ผู้ป่วยชาวไทยสูงอายุ ได้ให้...
1 year ago
**Expert Perspective: Side Effects and Management of CAR-T Therapy for a Thai Patient** At the Hematology Department of Shanghai Tongji Hospital, Dr. Li Ping, the chief physician for the elderly T...
1 year ago
Kymriah Novartis Price Kymriah, developed by Novartis, is a groundbreaking CAR-T cell therapy designed to treat certain types of blood cancers. However, its high cost has sparked significant discus...
1 year ago
Kymriah Mechanism of Action Kymriah, a groundbreaking immunotherapy, has redefined the landscape of cancer treatment. Its innovative mechanism of action harnesses the body’s own immune system...
1 year ago
Kymriah List Price The list price of Kymriah, a groundbreaking CAR-T cell therapy, is a staggering $475,000 for a single treatment course. This exorbitant cost has sparked intense debate over drug ...
1 year ago
**High Risk Multiple Myeloma Solution and Chinese Expert Consensus** Multiple Myeloma High risk multiple myeloma (HRMM) refers to patients with multiple myeloma whose overall survival is less than ...
1 year ago
Kymriah Launch Date Kymriah, a groundbreaking immunotherapy, has marked a new era in the treatment of hematological malignancies. This article delves into the pivotal launch dates of Kymriah for th...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
